Literature DB >> 19300987

Temporal dependence of in vivo USPIO-enhanced MRI signal changes in human carotid atheromatous plaques.

T Y Tang1, A J Patterson, S R Miller, M J Graves, S P S Howarth, J M U-King-Im, Z Y Li, U Sadat, V E Young, S R Walsh, J R Boyle, M E Gaunt, J H Gillard.   

Abstract

INTRODUCTION: Ultrasmall superparamagnetic iron oxide (USPIO)-enhanced MRI has been shown to be a useful modality to image activated macrophages in vivo, which are principally responsible for plaque inflammation. This study determined the optimum imaging time-window to detect maximal signal change post-USPIO infusion using T1-weighted (T1w), T2*-weighted (T2*w) and quantitative T2* (qT2*) imaging.
METHODS: Six patients with an asymptomatic carotid stenosis underwent high resolution T1w, T2*w and qT2* MR imaging of their carotid arteries at 1.5 T. Imaging was performed before and at 24, 36, 48, 72 and 96 h after USPIO (Sinerem, Guerbet, France) infusion. Each slice showing atherosclerotic plaque was manually segmented into quadrants and signal changes in each quadrant were fitted to an exponential power function to model the optimum time for post-infusion imaging.
RESULTS: The power function determining the mean time to convergence for all patients was 46, 41 and 39 h for the T1w, T2*w and qT2* sequences, respectively. When modelling each patient individually, 90% of the maximum signal intensity change was observed at 36 h for three, four and six patients on T1w, T2*w and qT2*, respectively. The rates of signal change decrease after this period but signal change was still evident up to 96 h.
CONCLUSION: This study showed that a suitable imaging window for T1w, T2*w and qT2* signal changes post-USPIO infusion was between 36 and 48 h. Logistically, this would be convenient in bringing patients back for one post-contrast MRI, but validation is required in a larger cohort of patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19300987     DOI: 10.1007/s00234-009-0523-x

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  16 in total

1.  Noninvasive imaging of carotid plaque inflammation.

Authors:  R A Trivedi; J M U-King-Im; M J Graves; P J Kirkpatrick; J H Gillard
Journal:  Neurology       Date:  2004-07-13       Impact factor: 9.910

2.  Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages.

Authors:  Rikin A Trivedi; Chinthake Mallawarachi; Jean-Marie U-King-Im; Martin J Graves; Jo Horsley; Martin J Goddard; Andrew Brown; Liqun Wang; Peter J Kirkpatrick; John Brown; Jonathan H Gillard
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-04-20       Impact factor: 8.311

3.  Utility of USPIO-enhanced MR imaging to identify inflammation and the fibrous cap: a comparison of symptomatic and asymptomatic individuals.

Authors:  S P S Howarth; T Y Tang; R Trivedi; R Weerakkody; J U-King-Im; M E Gaunt; J R Boyle; Z Y Li; S R Miller; M J Graves; J H Gillard
Journal:  Eur J Radiol       Date:  2008-03-19       Impact factor: 3.528

4.  Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits.

Authors:  S G Ruehm; C Corot; P Vogt; S Kolb; J F Debatin
Journal:  Circulation       Date:  2001-01-23       Impact factor: 29.690

5.  Use of gamma distributed residence times in pharmacokinetics.

Authors:  M Weiss
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Phase I clinical evaluation of a new iron oxide MR contrast agent.

Authors:  S J McLachlan; M R Morris; M A Lucas; R A Fisco; M N Eakins; D R Fowler; R B Scheetz; A Y Olukotun
Journal:  J Magn Reson Imaging       Date:  1994 May-Jun       Impact factor: 4.813

7.  Negative power functions of time in pharmacokinetics and their implications.

Authors:  M E Wise
Journal:  J Pharmacokinet Biopharm       Date:  1985-06

8.  Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging.

Authors:  T S Hatsukami; R Ross; N L Polissar; C Yuan
Journal:  Circulation       Date:  2000-08-29       Impact factor: 29.690

9.  Comparison of the inflammatory burden of truly asymptomatic carotid atheroma with atherosclerotic plaques in patients with asymptomatic carotid stenosis undergoing coronary artery bypass grafting: an ultrasmall superparamagnetic iron oxide enhanced magnetic resonance study.

Authors:  T Y Tang; S P S Howarth; S R Miller; M J Graves; J M U-King-Im; Z Y Li; S R Walsh; P D Hayes; K Varty; J H Gillard
Journal:  Eur J Vasc Endovasc Surg       Date:  2008-01-02       Impact factor: 7.069

10.  In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI.

Authors:  Rikin A Trivedi; Jean-Marie U-King-Im; Martin J Graves; Justin J Cross; Jo Horsley; Martin J Goddard; Jeremy N Skepper; George Quartey; Elizabeth Warburton; Ilse Joubert; Liqun Wang; Peter J Kirkpatrick; John Brown; Jonathan H Gillard
Journal:  Stroke       Date:  2004-05-27       Impact factor: 7.914

View more
  9 in total

1.  Characterization of carotid artery plaques with USPIO-enhanced MRI: assessment of inflammation and vascularity as in vivo imaging biomarkers for plaque vulnerability.

Authors:  Stephan Metz; Ambros J Beer; Marcus Settles; Jaroslav Pelisek; René M Botnar; Ernst J Rummeny; Peter Heider
Journal:  Int J Cardiovasc Imaging       Date:  2010-10-24       Impact factor: 2.357

Review 2.  Nanoparticles as magnetic resonance imaging contrast agents for vascular and cardiac diseases.

Authors:  Wei Chen; David P Cormode; Zahi A Fayad; Willem J M Mulder
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2010-10-21

3.  A Multimodal Nanocomposite for Biomedical Imaging.

Authors:  Aiguo Wu; Tatjana Paunesku; Zhuoli Zhang; Stefan Vogt; Barry Lai; Jörg Maser; Vahid Yaghmai; Debiao Li; Reed A Omary; Gayle E Woloschak
Journal:  AIP Conf Proc       Date:  2011-09-09

4.  Mapping Extracellular pH of Gliomas in Presence of Superparamagnetic Nanoparticles: Towards Imaging the Distribution of Drug-Containing Nanoparticles and Their Curative Effect on the Tumor Microenvironment.

Authors:  Samuel Maritim; Daniel Coman; Yuegao Huang; Jyotsna U Rao; John J Walsh; Fahmeed Hyder
Journal:  Contrast Media Mol Imaging       Date:  2017-11-22       Impact factor: 3.161

Review 5.  Application of Light Scattering Techniques to Nanoparticle Characterization and Development.

Authors:  Patrícia M Carvalho; Mário R Felício; Nuno C Santos; Sónia Gonçalves; Marco M Domingues
Journal:  Front Chem       Date:  2018-06-25       Impact factor: 5.221

Review 6.  Molecular Imaging in Ischemic Heart Disease.

Authors:  Begoña Lavin Plaza; Iakovos Theodoulou; Imran Rashid; Reza Hajhosseiny; Alkystis Phinikaridou; Rene M Botnar
Journal:  Curr Cardiovasc Imaging Rep       Date:  2019-06-11

7.  Ferumoxytol-enhanced three-dimensional magnetic resonance imaging of carotid atheroma- a feasibility and temporal dependence study.

Authors:  Ammara Usman; Andrew J Patterson; Jianmin Yuan; Alison Cluroe; Ilse Patterson; Martin J Graves; Jonathan H Gillard; Umar Sadat
Journal:  Sci Rep       Date:  2020-02-04       Impact factor: 4.379

Review 8.  Cardiovascular magnetic resonance in carotid atherosclerotic disease.

Authors:  Li Dong; William S Kerwin; Marina S Ferguson; Rui Li; Jinnan Wang; Huijun Chen; Gador Canton; Thomas S Hatsukami; Chun Yuan
Journal:  J Cardiovasc Magn Reson       Date:  2009-12-15       Impact factor: 5.364

9.  Contrast-enhanced MR imaging of atherosclerosis using citrate-coated superparamagnetic iron oxide nanoparticles: calcifying microvesicles as imaging target for plaque characterization.

Authors:  Susanne Wagner; Jörg Schnorr; Antje Ludwig; Verena Stangl; Monika Ebert; Bernd Hamm; Matthias Taupitz
Journal:  Int J Nanomedicine       Date:  2013-02-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.